Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fakharzadeh

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The British Journal of Dermatology|February 24, 2012
Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 yearsA B Kimball, K B Gordon, S Fakharzadeh, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 18, 2013
Volatile biomarkers from human melanoma cellsJae Kwak, Michelle Gallagher, Mehmet Hakan Ozdener, et al.
Blood|June 19, 2008
Clinical and in vitro resistance to bexarotene in adult T-cell leukemia: loss of RXR-alpha receptorJulie H Lin, Ellen J Kim, Anand Bansal, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 31, 2016
Drug survival of biologic therapy in a large, disease-based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)A Menter, K A Papp, M Gooderham, et al.
The British Journal of Dermatology|July 12, 2008
Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositisR Q Klein, C A Bangert, M Costner, et al.
Blood|July 26, 2003
Factor VIII ectopically expressed in platelets: efficacy in hemophilia A treatmentHelen V Yarovoi, Dubravka Kufrin, Don E Eslin, et al.
Current Drug Metabolism|April 8, 2003
Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuriaJohn R Cashman, Kathryn Camp, Steven S Fakharzadeh, et al.
The British Journal of Dermatology|June 11, 2017
Extension of ustekinumab maintenance dosing interval in moderate-to-severe psoriasis: results of a phase IIIb, randomized, double-blinded, active-controlled, multicentre study (PSTELLAR)A Blauvelt, L K Ferris, P S Yamauchi, et al.
The Journal of Investigative Dermatology|January 6, 2012
Evaluation of reliability, validity, and responsiveness of the CDASI and the CAT-BMRenato Goreshi, Joyce Okawa, Matt Rose, et al.
Cancer Biology & Therapy|March 12, 2009
Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissuesChangqing Ma, Kelly M Quesnelle, Anthony Sparano, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The British Journal of Dermatology|February 24, 2012
Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 yearsA B Kimball, K B Gordon, S Fakharzadeh, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 18, 2013
Volatile biomarkers from human melanoma cellsJae Kwak, Michelle Gallagher, Mehmet Hakan Ozdener, et al.
Blood|June 19, 2008
Clinical and in vitro resistance to bexarotene in adult T-cell leukemia: loss of RXR-alpha receptorJulie H Lin, Ellen J Kim, Anand Bansal, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 31, 2016
Drug survival of biologic therapy in a large, disease-based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)A Menter, K A Papp, M Gooderham, et al.
The British Journal of Dermatology|July 12, 2008
Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositisR Q Klein, C A Bangert, M Costner, et al.
Blood|July 26, 2003
Factor VIII ectopically expressed in platelets: efficacy in hemophilia A treatmentHelen V Yarovoi, Dubravka Kufrin, Don E Eslin, et al.
Current Drug Metabolism|April 8, 2003
Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuriaJohn R Cashman, Kathryn Camp, Steven S Fakharzadeh, et al.
The British Journal of Dermatology|June 11, 2017
Extension of ustekinumab maintenance dosing interval in moderate-to-severe psoriasis: results of a phase IIIb, randomized, double-blinded, active-controlled, multicentre study (PSTELLAR)A Blauvelt, L K Ferris, P S Yamauchi, et al.
The Journal of Investigative Dermatology|January 6, 2012
Evaluation of reliability, validity, and responsiveness of the CDASI and the CAT-BMRenato Goreshi, Joyce Okawa, Matt Rose, et al.
Cancer Biology & Therapy|March 12, 2009
Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissuesChangqing Ma, Kelly M Quesnelle, Anthony Sparano, et al.
Pageof 2